Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question Catalina GURAN, Mieta-Gabriela HATEGAN, Dacian Nicolae OROS, Despina CALAMAR-POPOVICI, Marioara IONITA HORTENSIA, Claudiu IONITA, Florica...

Antiphospholipid Antibodies in Non-Hodgkin’s Lymphoma

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

Antiphospholipid Antibodies in Non-Hodgkin’s Lymphoma Sanda BURUIANA, Maria ROBU, Victor TOMACINSCHII, Minodora MAZUR, Lucia MAZUR-NICORICI Introduction: Non-Hodgkin’s lymphomas (NHL) are a heterogeneous group of malignant lymphoid tumors. Anticardiolipin...

17p13.1 Deletion in Small B-cell Lymphocytic Lymphomas: A Prognostic Factor and Diagnostic Approach

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

17p13.1 Deletion in Small B-cell Lymphocytic Lymphomas: A Prognostic Factor and Diagnostic Approach Andreea-Georgiana STOICA, Miruna CRISTIAN, Mariana ASCHIE, Anca-Florentina MITROI, Georgiana-Camelia COZARU, Gabriela-Izabela BALTATESCU, Mădălina BOSOTEANU1,...

DRD vs. D-VCD in Newly Diagnosed AL Amyloidosis: A Retrospective Single-Center Study

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

DRD vs. D-VCD in Newly Diagnosed AL Amyloidosis: A Retrospective Single-Center Study Larisa ZIDARU, Andreea JERCAN, Sinziana BARBU, Daniel Nicolae MURARIU, Daniel CORIU, Sorina Nicoleta BADELITA Aim: This study evaluates hematologic responses in AL amyloidosis...

IgA Myeloma at Diagnosis – Clinical, Paraclinical Characteristics and Response to First Line of Treatment

by Catalin | Dec 19, 2024 | 2024 vol. 2 Issue 4

IgA Myeloma at Diagnosis – Clinical, Paraclinical Characteristics and Response to First Line of Treatment Mara Caterina BĂLAN, Mihai Emilian LĂPĂDAT, Anca Mariana CIOBANU, Irina Nicoleta TRIANTAFYLLIDIS, Oana STANCA Abstract Objectives: Real-life data on IgA-secretory...